Clinical Trials Directory

436 clinical trials found.
Research for Children and Teenagers

We are building a database of people who would like to be contacted about future dermatology research studies. This is a way for people who are interested in participating in research opportunities to learn about a research study that they may not have otherwise known about.

Compensation: No
Ages: 0-110
Non-Oncology
Remote/online
Eyes and Vision

We are doing this study to find out if an experimental drug called DF-003 is a safe and effective option for people with ROSAH Syndrome.

Compensation: No
Ages: 18-65
Non-Oncology
Duke University Hospital
Breast Cancer

We are doing this study to test the safety and effectiveness of the study drug, datopotamab deruxtecan (also known as dato-DXd), and find out if it is a potential option for patients with metastatic breast cancer that has spread to the brain and/or spinal cord.

Compensation: No
Ages: 18-110
Oncology
Duke University Hospital, Duke Raleigh Hospital
Research for Healthy Adults

We are doing this study to find out if an experimental vaccine called Cov-RBD-scNP-001 (the study vaccine) provides safe and effective protection against multiple different coronaviruses, including the virus that causes COVID-19. We want to know the effects of the vaccine when it's given at 3 different dose levels.

Compensation: Yes
Ages: 18-55
Non-Oncology
Other
Vaccine

We are doing this study to find out if an experimental vaccine is a safe and effective option to protect against H5 avian influenza (bird flu).

Compensation: Yes
Ages: 18-49
Non-Oncology
Other
Brain, Spinal Cord and Nerves

We are doing this study to find out if an investigational drug called iptacopan (the study drug) is safe and has beneficial effects for people who have generalized Myasthenia Gravis (gMG).

Compensation: Yes
Ages: 18-75
Non-Oncology
Duke University Hospital
Immunology and Rheumatology

We are doing this study to find out if an experimental drug called CABA-201 (the study drug) is a safe and effective option for people with systemic sclerosis.

Compensation: Yes
Ages: 18-75
Non-Oncology
Duke University Hospital
Eyes and Vision

We are doing this study to find out if an experimental drug called tinlarebant is a safe and effective option for people with Stargardt Disease.

Compensation: No
Ages: 12-20
Non-Oncology
Duke University Hospital